Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide
Abstract
Share and Cite
Doello, K.; Chico, M.A.; Quiñonero, F.; Ortiz, R.; Prados, J.; Mesas, C.; Melguizo, C. Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide. Medicina 2024, 60, 1039. https://doi.org/10.3390/medicina60071039
Doello K, Chico MA, Quiñonero F, Ortiz R, Prados J, Mesas C, Melguizo C. Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide. Medicina. 2024; 60(7):1039. https://doi.org/10.3390/medicina60071039
Chicago/Turabian StyleDoello, Kevin, Maria Angeles Chico, Francisco Quiñonero, Raúl Ortiz, Jose Prados, Cristina Mesas, and Consolación Melguizo. 2024. "Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide" Medicina 60, no. 7: 1039. https://doi.org/10.3390/medicina60071039